Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 216841
Company: HETERO LABS LTD III

Products on ANDA 216841

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
RUFINAMIDE	RUFINAMIDE	40MG/ML	SUSPENSION;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 216841

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
12/05/2023	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 216841

RUFINAMIDE

SUSPENSION;ORAL; 40MG/ML
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
BANZEL	RUFINAMIDE	40MG/ML	SUSPENSION;ORAL	Prescription	Yes	AB	201367	EISAI INC
RUFINAMIDE	RUFINAMIDE	40MG/ML	SUSPENSION;ORAL	Prescription	No	AB	213410	ALKEM LABS LTD
RUFINAMIDE	RUFINAMIDE	40MG/ML	SUSPENSION;ORAL	Prescription	No	AB	216549	AUROBINDO PHARMA
RUFINAMIDE	RUFINAMIDE	40MG/ML	SUSPENSION;ORAL	Prescription	No	AB	211388	BIONPHARMA
RUFINAMIDE	RUFINAMIDE	40MG/ML	SUSPENSION;ORAL	Prescription	No	AB	214009	CHARTWELL RX
RUFINAMIDE	RUFINAMIDE	40MG/ML	SUSPENSION;ORAL	Prescription	No	AB	216841	HETERO LABS LTD III
RUFINAMIDE	RUFINAMIDE	40MG/ML	SUSPENSION;ORAL	Prescription	No	AB	207363	HIKMA
RUFINAMIDE	RUFINAMIDE	40MG/ML	SUSPENSION;ORAL	Prescription	No	AB	213457	LUPIN
RUFINAMIDE	RUFINAMIDE	40MG/ML	SUSPENSION;ORAL	Prescription	No	AB	214817	MSN